KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Cash from Financing Activities (2017 - 2025)

Historic Cash from Financing Activities for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to $10.1 million.

  • Bionano Genomics' Cash from Financing Activities rose 6734.76% to $10.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.3 million, marking a year-over-year decrease of 4828.81%. This contributed to the annual value of -$13.7 million for FY2024, which is 11202.39% down from last year.
  • Bionano Genomics' Cash from Financing Activities amounted to $10.1 million in Q3 2025, which was up 6734.76% from $1.5 million recorded in Q2 2025.
  • In the past 5 years, Bionano Genomics' Cash from Financing Activities registered a high of $337.5 million during Q1 2021, and its lowest value of -$21.6 million during Q1 2024.
  • For the 5-year period, Bionano Genomics' Cash from Financing Activities averaged around $25.4 million, with its median value being $6.0 million (2024).
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first surged by 21221428.57% in 2023, then crashed by 24545.82% in 2024.
  • Quarter analysis of 5 years shows Bionano Genomics' Cash from Financing Activities stood at $2.0 million in 2021, then crashed by 92.58% to $146000.0 in 2022, then skyrocketed by 46806.85% to $68.5 million in 2023, then plummeted by 94.32% to $3.9 million in 2024, then soared by 159.02% to $10.1 million in 2025.
  • Its Cash from Financing Activities was $10.1 million in Q3 2025, compared to $1.5 million in Q2 2025 and $10.9 million in Q1 2025.